VitalPath Strategic Marketing VP Bridget Locke [Photo courtesy of VitalPath]
The New Hope, Minnesota-based contract development and manufacturing organization said recent cleanroom investments at its Maplewood, Minnesota catheter development and manufacturing site increased overall capacity by 40% and optimized product flow. The company also upgraded its New Hope R&D design center cleanroom from class 8 to class 7.
“These facility investments paired with the company’s catheter component and laser expertise out of Cokato, Minnesota, means strategic customer partnerships are supported with a comprehensive breadth of vertically integrated capabilities to set the stage for continued growth,” the company said in a news release.
Joining VitalPath’s executive ranks is Strategic Marketing VP Bridget Locke, who the company hired earlier this year as senior director, strategic marketing. Locke will continue to develop and execute brand strategy in her new role, but now has increased sales operations responsibilities to drive business growth and increase market share, the company said.
“I am continually impressed by Bridget’s unique ability to swiftly evaluate the marketing efforts of a medtech organization and develop holistic strategic plans that achieve both internal and external objectives, driving brand awareness and significant growth,” Chief Commercial Officer Rich Rivard said in the news release. “Her expertise in marketing and sales operations, combined with her hands-on approach and ability to relate to all functions and levels of an organization, makes Bridget a valued leader. Bridget consistently demonstrates the VitalPath mission and values through her dedication, strategic vision, and collaborative spirit, which inspires and drives our team forward.”
Before joining VitalPath, Locke was at CDMO’s including Vantedge Medical, Medevio, ATL Technology and Northwire.
“I am delighted to have this opportunity to continue to evolve our marketing and sales operations at VitalPath,” she said in the news release. “The contributions that the VitalPath team makes to the medtech community is truly inspiring. We have many exciting and impactful projects underway, but at the end of the day, we aim to amplify the impact of our mission to dramatically improve the quality of patient lives in partnership with our vital customers.”
